Estrogen 

Estrogen and Bone Fractures

In a study done at the Mayo Clinic on 338 postmenopausal women who had undergone bilateral oophorectomy (removal of both ovaries) and were then followed for an average of 16 years, the risk of bone fractures was 50% higher than the expected community rate. Vertebral fractures occurred three times more often. Treatment with estrogen reduced the 50% increase to 30%.   Prophylactic removal of ovaries in postmenopausal women is not indicated except in specific high risk situations.

Estrogen Not to Blame

A new study from Yale shows that women who take estrogen alone after a hysterectomy do not increase their risk for breast cancer. That points to progesterone, especially the synthetic Provera as the culprit, and suggests "RU-486", an "antiprogesterone", as useful in hysterectomized women

                                                       MONITORING ESTROGEN REPLACEMENT

Estrogen replacement - There is now and has been for quite some time a lack of understanding in the medical community concerning whether to monitor estrogen replacement with periodic blood levels, and if so, how? In 1942, a new drug appeared on the U.S. market called Premarin. It was the first commercially available estrogen.

It was manufactured by extraction from pregnant horse urine (PREgnant- MARe's-urINe!). It contained a hodge-podge of estrogenic compounds, pre-dominately estrone, a weak estrogen found in humans, and equlin, a more potent estrogen found in horses but not humans.

Neither was really estradiol, the most important human estrogen. Blood levels of equilin could not be measured then and have never been available by commercial medical laboratories since.

The mixture of estrogenic compounds in Premarin was so complex and variable that to this day the Federal Drug Administration has not allowed a generic copy of Premarin on the market. The pharmaceutical company with the patent for Premarin had the market cornered, and, as the concept of estrogen replacement gained momentum in the 1960's, brilliantly promoted their product. It is, at present, the most widely prescribed estrogen; in fact it is, at present, the most widely prescribed drug of any kind in the United States.

The horses used to produce it, however, are all in Canada, since the Society for Prevention of Cruelty to Animals in this country has raised such a fuss about the inhumane treatment of the animals.

Nevertheless, the promotion of Premarin that has been and still is being carried out is even better than De Beer's promotion of diamonds. Little wonder that virtually all studies involving estrogen that are done in this country use Premarin, since the company volunteers to supply it at no cost. Consequently, the words "estrogen" and "Premarin" have become synonymous in the U.S., much as "refrigerator" and Fridgidaire" were in the 1940's.

Because blood levels are never measured when Premarin is used, all these studies are of limited (if any) value.

The results cannot be extrapolated to mimic those that would be realized if real human estradiol were used and serum blood levels measured and correlated.

Another problem with Premarin deals with route of administration and absorption. Any estrogen taken by mouth (orally) is subjected to the vagaries of intestinal absorption. This is dependent on whether the estrogen is taken on a full or empty stomach and with what liquid. For instance, alcohol or grapefruit juice may triple the absorption through the intestinal wall. Even more important is the so called "first pass effect" by the liver. Any estrogen taken orally goes from the intestine via the "portal" circulation to the liver. The first time through the liver, the estrogen causes an increased risk of gallstones, hypertension, abnormal blood clotting, and weight gain. Estrogen used non-orally does not cause these problems. Since Premarin cannot be accurately measured in the blood, a "standard" daily dose of 0.625 mgm, has been agreed upon.

Thus, it is the only drug of which I am aware that is given to everyone in the same amount regardless of weight, age, symptoms, cardiovascular or bone status, etc. For a variety of reasons, the best way to replace the declining and fluctuating  blood levels of estradiol coming from the ovaries is with real human estradiol, given non-orally (not by mouth).

This makes accurate measurement of blood levels of estradiol essential. Can estradiol levels in the blood be accurately measured? Yes, now that we have radio-immunoassay (RIA). This technique allows measurement of substances in the blood in amounts of trillionths of a gram (picograms), which are the units used in measuring hormone levels. But, we must be even more precise than that when measuring certain hormones: estradiol, testosterone, cortisol, thyroxin, and progesterone.

These hormones are bound, in large part, to globulins (proteins) in the blood. For instance, estrogen binding globulin ties up 98-99% of the estradiol in the blood.

It measures on the estradiol test but is completely biologically inactive. What we really need to measure is how much "free" biologically active estradiol is present. The same thing applies to thyroid hormone (free thyroxin and free T3), male hormone (free testosterone) and the adrenal hormone cortisol (free cortisol).

The percentage of free estradiol is very constant at any given time in the menstrual cycle or post menopausally. Therefore, after an initial measurement of free estradiol and % of free estradiol, one can follow "total" estradiols, which are cheaper, and multiply by % of free estradiol to determine the free amount. Very few laboratories in this country have the equipment and personnel to measure free estradiols. No labs in Dallas do so. We, therefore, send the blood to InterScience Institute in Inglewood, California.

There is still an even more confusing situation. The majority of medical laboratories measure estradiol levels using a "kit" test. There are several "kits" available. These were developed about 30 years ago when a fertility drug named Pergonal came on the market. The daily injections of Pergonal required a rapid test for estradiol that could be done in a few hours.

There are three steps necessary to the accurate measurement of total estradiol. They are:

1) Extraction

2) Chromatography separatio,

3) RIA

Kit testing leaves out the first two steps, resulting in many impurities and metabolites still being in the blood serum when the third step, RIA, is performed. The result is 8-10 times inaccurate on the high side, which can be corrected for if you are measuring estradiol for fertility, but not if you are using it for hormone replacement. Some labs caution about that in their report (Smith-Kline-Beecham for example); most do not. Doctors who aren't aware of this huge discrepancy are fooled into thinking the patient has a much higher total estradiol level than she actually has, not to mention making the free estradiol level totally incorrect and misleading as well.

The target range for free estradiol in a peri menopausal or post menopausal woman has been determined to be 0.5-1.5 picograms/ml. In a woman with a normal % of free estradiol, 0.8-1.5%, this corresponds to a total estradiol of 50-100 picograms/ml. This level provides the maximum in cardiovascular and bone protection and protection against Alzheimer's disease and also is the level at which most women feel the best.

The best methods to obtain these blood levels are non-oral estradiol, i.e., topical cream, patches, or subcutaneous estradiol pellets. No valid study has ever shown any advantage to adding either of the other two human estrogens: estriol and estrone, neither of which change during menopause. Adding either or both of these (Bi-Est or Tri-Est) increases the cost by one third, with no benefit.

 One further word about evaluating estradiol dosage. A blood FSH (follicle stimulating hormone) is not useful. It does not have a reciprocal relationship to estradiol such as TSH does with thyroxin. A third hormone, inhibin, blocks that reciprocal relationship. If you have further questions concerning monitoring your blood hormone level, feel free to bring them up to me.

  A review of the literature reveals no evidence of an increased risk of blood clots (thrombosis or thromboembolism) in non oral estrogen users as compared to controls. Non-oral estrogen (Estradiol cream, pellets, or patches) does not get a "first pass" through the liver, which adversely effects blood clotting factors. Oral estrogen ("Premarin," certain birth control pills, Estrace) does increase the tendency toward blood clotting, and it is dose related. The higher the dose of oral estrogen, the greater the risk.

 

 

Categories:

 

Check out our
NEWSLETTER!

 

Special Bulletin

Cooper Study
Click here to Download studys done
at Cooper Clinic in Dallas TX.

    Hormones and Menopause

    This website does not guarantee data accuracy and disclaims any and all liability.

    Copyright 2008 www.abouthormones.org all rights reserved.

    John R. Woodward, M.D.,P.A.
    7777 Forest Lane, Suite A338
    Dallas, Texas 75230
    (972) 566-7870